HEART FAILURE WITH REDUCED EJECTION FRACTION
Clinical trials for HEART FAILURE WITH REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart failure and AF patients to get Game-Changing procedure showdown
Disease control Not yet recruitingThis study compares two procedures—catheter ablation and pacemaker therapy—for people with both atrial fibrillation (irregular heartbeat) and heart failure. About 1,056 adults will be randomly assigned to one of the two treatments. The goal is to see which approach better reduces…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE4 • Sponsor: University of British Columbia • Aim: Disease control
Last updated May 17, 2026 04:32 UTC
-
Can a blood pressure pill unlock life-saving heart failure treatments?
Disease control Not yet recruitingThis study tests whether midodrine, a drug that raises blood pressure, can help people with heart failure and low blood pressure tolerate the standard heart medications that save lives. About 56 adults with weak hearts and low blood pressure will be randomly assigned to get midod…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE2, PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New device zaps lung arteries to ease heart failure
Disease control Not yet recruitingThis study tests a device that uses radiofrequency energy to treat high blood pressure in the lungs of people with heart failure. The treatment aims to reduce serious heart events like hospitalizations or death. About 750 adults with stable heart failure will be randomly assigned…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Pulnovo Medical, Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
One pill to treat heart failure: could a polypill save lives in sri lanka?
Disease control Not yet recruitingThis study tests whether a single pill containing four standard heart failure medications can help people with a weak heart pump (ejection fraction 40% or less) live longer and avoid hospital stays. About 1,656 adults in Sri Lanka will either receive the polypill or usual care, a…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Heart stents vs. pills: which works better for failing hearts?
Disease control Not yet recruitingThis study compares two treatments for people with heart failure and a weak heart pump (ejection fraction 40% or less) caused by blocked arteries. One group gets heart stents plus standard medications, the other gets medications alone. The goal is to see which approach better pre…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated May 07, 2026 18:39 UTC